First AD

Second AD

Lung Cancer

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Oncology Business Management

 Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

Precision Medicine in Oncology®

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

Immuno-Oncology

Immunotherapy in Lung Cancer

The OncLive Immunotherapy in Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on available and investigational immunotherapies in lung cancer. This page features news articles, interviews in written and video format, and podcasts that focus on updates with checkpoint inhibitors and the ongoing research with this type of treatment in non–small cell lung cancer and small cell lung cancer.

Emerging Treatment Paradigms for Advanced Lung Cancer

Peer Exchange

Driver Mutations Trump PD-L1 Expression in Lung Adenocarcinoma

Impact of PACIFIC Trial on Locally Advanced NSCLC

The Role of Surgery in NSCLC Following PACIFIC Trial

Imaging Schedule Following CRT in Locally Advanced NSCLC

Biomarker Testing in Stage III NSCLC

Choosing Therapy for Newly Diagnosed NonDriver NSCLC

Looking at the IMpower Data in NSCLC

CheckMate-227 and the Role of TMB in NSCLC

Treatment Options for mNSCLC After Progression

A Win for Small-Cell Lung Cancer: IMPOWER 133

ADRIATIC Trial in Locally Advanced Small-Cell Lung Cancer

Molecular Testing for NSCLC in 2019

Osimertinib, the Standard for EGFR+ NSCLC

Resistance Mechanisms in EGFR+ NSCLC

Available Therapies for ALK-Rearranged NSCLC

A Game-Changing Year for NSCLC